Cardio Diagnostics Holdings, Inc. Operating Cash Flow
Cardio Diagnostics Holdings, Inc. (CDIO) reported Operating Cash Flow of -$2.90 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-07
- Cardio Diagnostics Holdings, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$1.34M.
- Cardio Diagnostics Holdings, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$1.56M.
- Cardio Diagnostics Holdings, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$1.36M.
- Cardio Diagnostics Holdings, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$1.39M.
- Cardio Diagnostics Holdings, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$5.73M.
- Cardio Diagnostics Holdings, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$4.99M.
- Cardio Diagnostics Holdings, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$5.67M.
- Cardio Diagnostics Holdings, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$5.09M.
| Period end | Net Cash Provided by (Used in) Operating Activities 1 month | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 4 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 7 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$2.90M 10-Q · filed 2026-08-07 | -$4.27M derived: sum of 3 quarters · filed 2026-08-07 | -$5.66M derived: sum of 4 quarters · filed 2026-08-07 | ||||||
| 2026-03-31 | -$1.56M 10-Q · filed 2026-05-15 | -$2.92M derived: sum of 2 quarters · filed 2026-05-15 | -$4.32M derived: sum of 3 quarters · filed 2026-05-15 | -$5.89M derived: sum of 4 quarters · filed 2026-08-07 | ||||||
| 2025-12-31 | -$1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$2.76M derived: sum of 2 quarters · filed 2026-03-13 | -$4.33M derived: sum of 3 quarters · filed 2026-08-07 | -$5.73M 10-K · filed 2026-03-13 | ||||||
| 2025-09-30 | -$1.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$2.96M derived: sum of 2 quarters · filed 2026-08-07 | -$4.36M 10-Q · filed 2025-11-12 | -$5.76M derived: sum of 4 quarters · filed 2026-08-07 | ||||||
| 2025-06-30 | -$1.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$2.97M 10-Q · filed 2026-08-07 | -$4.36M derived: sum of 3 quarters · filed 2026-08-07 | -$5.52M derived: sum of 4 quarters · filed 2026-08-07 | ||||||
| 2025-03-31 | -$1.40M 10-Q · filed 2026-05-15 | -$2.79M derived: sum of 2 quarters · filed 2026-05-15 | -$3.95M derived: sum of 3 quarters · filed 2026-05-15 | -$5.16M derived: sum of 4 quarters · filed 2026-05-15 | ||||||
| 2024-12-31 | -$1.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$2.55M derived: sum of 2 quarters · filed 2026-03-13 | -$3.76M derived: sum of 3 quarters · filed 2026-03-13 | -$4.99M 10-K · filed 2026-03-13 | ||||||
| 2024-09-30 | -$1.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$2.37M derived: sum of 2 quarters · filed 2025-11-12 | -$3.60M 10-Q · filed 2025-11-12 | -$5.29M derived: sum of 4 quarters · filed 2025-11-12 | ||||||
| 2024-06-30 | -$1.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$2.44M 10-Q · filed 2025-08-14 | -$4.13M derived: sum of 3 quarters · filed 2025-08-14 | -$5.17M derived: sum of 4 quarters · filed 2025-08-14 | ||||||
| 2024-03-31 | -$1.23M 10-Q · filed 2025-05-15 | -$2.92M derived: sum of 2 quarters · filed 2025-05-15 | -$3.96M derived: sum of 3 quarters · filed 2025-05-15 | -$5.26M derived: sum of 4 quarters · filed 2025-05-15 | ||||||
| 2023-12-31 | -$1.69M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | -$2.73M derived: sum of 2 quarters · filed 2025-03-20 | -$4.02M derived: sum of 3 quarters · filed 2025-03-20 | -$5.67M 10-K · filed 2025-03-20 | ||||||
| 2023-09-30 | -$1.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | -$2.34M derived: sum of 2 quarters · filed 2024-11-13 | -$3.99M 10-Q · filed 2024-11-13 | -$7.11M derived: sum of 4 quarters · filed 2024-11-13 | ||||||
| 2023-06-30 | -$1.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$2.94M 10-Q · filed 2024-08-12 | -$6.06M derived: sum of 3 quarters · filed 2024-08-12 | -$7.45M derived: sum of 4 quarters · filed 2024-08-12 | ||||||
| 2023-03-31 | -$1.65M 10-Q · filed 2024-05-15 | -$4.77M derived: sum of 2 quarters · filed 2024-05-15 | -$6.16M derived: sum of 3 quarters · filed 2024-05-15 | -$6.55M derived: sum of 4 quarters · filed 2024-05-15 | ||||||
| 2022-12-31 | -$3.12M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$4.51M derived: sum of 2 quarters · filed 2024-04-01 | -$4.90M derived: sum of 3 quarters · filed 2024-04-01 | -$5.09M 10-K · filed 2024-04-01 | ||||||
| 2022-09-30 | -$1.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$1.78M derived: sum of 2 quarters · filed 2023-11-13 | -$1.97M 10-Q · filed 2023-11-13 | -$587.02K 10-Q · filed 2022-11-07 | ||||||
| 2022-06-30 | -$394.77K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$580.86K 10-Q · filed 2023-08-14 | -$481.04K 10-Q · filed 2022-08-10 | |||||||
| 2022-03-31 | -$186.09K 10-Q · filed 2023-05-15 | -$146.01K 10-Q · filed 2022-05-12 | ||||||||
| 2021-12-31 | -$300.94K 10-K · filed 2022-03-31 | -$585.29K 10-K · filed 2023-03-31 | ||||||||
| 2021-09-30 | -$174.00 10-Q · filed 2022-11-07 | |||||||||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |